BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26719098)

  • 1. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.
    Rohr J; Guo S; Huo J; Bouska A; Lachel C; Li Y; Simone PD; Zhang W; Gong Q; Wang C; Cannon A; Heavican T; Mottok A; Hung S; Rosenwald A; Gascoyne R; Fu K; Greiner TC; Weisenburger DD; Vose JM; Staudt LM; Xiao W; Borgstahl GE; Davis S; Steidl C; McKeithan T; Iqbal J; Chan WC
    Leukemia; 2016 May; 30(5):1062-70. PubMed ID: 26719098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.
    Watanabe R; Harada Y; Takeda K; Takahashi J; Ohnuki K; Ogawa S; Ohgai D; Kaibara N; Koiwai O; Tanabe K; Toma H; Sugamura K; Abe R
    J Immunol; 2006 Jul; 177(2):1085-91. PubMed ID: 16818765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
    Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
    Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Moon CS; Reglero C; Cortes JR; Quinn SA; Alvarez S; Zhao J; Lin WW; Cooke AJ; Abate F; Soderquist CR; Fiñana C; Inghirami G; Campo E; Bhagat G; Rabadan R; Palomero T; Ferrando AA
    Nat Cancer; 2021 Jan; 2(1):98-113. PubMed ID: 33928261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
    Sandell RF; Boddicker RL; Feldman AL
    Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
    Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
    J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
    Tigu AB; Bancos A
    Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.
    Zhan HQ; Li XQ; Zhu XZ; Lu HF; Zhou XY; Chen Y
    J Clin Pathol; 2011 Apr; 64(4):319-24. PubMed ID: 21330314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
    Sakata-Yanagimoto M; Chiba S
    Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
    Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.
    Martínez-Delgado B; Cuadros M; Honrado E; Ruiz de la Parte A; Roncador G; Alves J; Castrillo JM; Rivas C; Benítez J
    Leukemia; 2005 Dec; 19(12):2254-63. PubMed ID: 16270046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.